Organon & Co
719 hedge funds and large institutions have $3.75B invested in Organon & Co in 2024 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 233 increasing their positions, 247 reducing their positions, and 79 closing their positions.
600% more funds holding in top 10
Funds holding in top 10: 1 → 7 (+6)
28% more capital invested
Capital invested by funds: $2.94B → $3.75B (+$810M)
9% more first-time investments, than exits
New positions opened: 86 | Existing positions closed: 79
0% more funds holding
Funds holding: 718 → 719 (+1)
0% less call options, than puts
Call options by funds: $55M | Put options by funds: $55.2M
6% less repeat investments, than reductions
Existing positions increased: 233 | Existing positions reduced: 247
1.74% less ownership
Funds ownership: 79.74% → 78% (-1.7%)
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$33.8M |
| 2 |
DRZID
DePrince Race & Zollo Inc (DRZ)
Winter Park,
Florida
|
+$32.2M |
| 3 |
SPC
Slate Path Capital
New York
|
+$26.9M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$21.5M |
| 5 |
KBG
Kahn Brothers Group
New York
|
+$19.6M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$115M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$46M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$37.8M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$21.4M |
| 5 |
Squarepoint
New York
|
-$20.8M |
OGN Hedge Fund Activity: Q1 2024 in Review
719 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q1 2024, worth a combined $3.75B — up 28% from $2.94B a quarter earlier.
Buyers outnumbered sellers: 86 funds opened new OGN positions and 79 closed out — a net gain of 7 holders — while 233 added to existing stakes and 247 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $33.8M. The largest seller was Morgan Stanley, cutting an estimated $115M.
- 719 institutional investors held Organon & Co (OGN) as of Q1 2024, up from 718 in Q4 2023.
- Funds reported $3.75B of Organon & Co stock for Q1 2024, up 28% quarter-over-quarter.
- 86 funds opened new Organon & Co positions in Q1 2024 and 79 closed out, a net change of +7 holders.
- The largest Organon & Co buyer in Q1 2024 was Citadel Advisors, an estimated $33.8M added.
- The largest Organon & Co seller in Q1 2024 was Morgan Stanley, an estimated $115M sold.
Based on aggregated 13F filings for Q1 2024.